The White House in the United States says that if Beijing is required, the United States has prepared to provide China to provide assistance in response to the surge in the epidemic.
According to Reuters, the White House National Security Council spokesman Kobe told reporters on Wednesday (December 14) that Beijing has no relevant requirements.He said: "We have stated that we are going to help in any way they think they can accept."
After the Chinese epidemic prevention and control is loosened, the number of infections has soared. In the past weekSuddenly increase.When Chinese Vice Premier Sun Chunlan went to Beijing to investigate and guide the prevention and control of the epidemic on Tuesday (13th), he pointed out that the focus of work should be transferred from prevention and control infection to medical treatment. The medical system of various localities was pushed to the forefront of epidemic prevention work in the new stage.
According to the Wall Street Journal, according to the medical care platform 1 pharmaceutical network listed on the Nasdaq, the platform has begun to retail the oral crown disease of Pfizer in China.
The sales page of this Chinese platform shows that it now provides PAXLOVID, which is used by the Chinese government's crown disease drug approved by the Chinese government in February, for the use of clients for polymerase chain response or antigen test results.
Pfizer began producing Paxlovid in 2021.Since the new crown epidemic broke out in Shanghai in March, Paxlovid has been used by doctors to treat Chinese patients.
